- Immunoassay reagents and devices are vital tools in clinical diagnostics, used to detect and quantify specific proteins, hormones, and pathogens in biological samples. They are widely applied in disease screening, therapeutic monitoring, and drug testing, supporting accurate diagnosis and effective treatment decisions
- The immunoassay reagents and devices market is witnessing strong growth, driven by the rising burden of chronic and infectious diseases, technological advancements in assay platforms, and the growing demand for early and precise diagnostics. In addition, expanding healthcare infrastructure and increased adoption of automated and point-of-care systems are accelerating market expansion
- North America is expected to dominate the immunoassay reagents and devices market with a share of 47.93, due to the significant investments in research and development, robust government support, and a highly developed healthcare infrastructure
- Asia-Pacific is expected to be the fastest growing region in the immunoassay reagents and devices market during the forecast period due to increasing healthcare investments, rapid urbanization, and a growing demand for advanced diagnostic solutions across the region
- Reagents and kits segment is expected to dominate the market with a market share of 66.60% due to their recurring use in diagnostic procedures, increasing demand for high-throughput testing, and the rising prevalence of chronic and infectious diseases requiring continuous monitoring and rapid diagnostics
